












340A comparison between contrast-enhanced
ultrasound imaging and multislice computed
tomography in detecting and classifying endoleaks
in the follow-up after endovascular aneurysm repair
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Background: This study compared contrast-enhanced ultrasound (CEUS) imaging and multislice computed tomography
(MS-CT) angiography in detecting and classifying endoleaks in the follow-up of patients after endovascular aneurysm
repair (EVAR).
Methods: This retrospective study consisted of 171 patients with CEUS imaging and MS-CT angiography follow-up
examinations after EVAR. During follow-up, 489 CEUS and 421 MS-CT examinations were assessed. B-scan, color
Doppler, and CEUS imaging were performed in all patients. MS-CT was performed with a 16-slice up to 128-slice
scanner.
Results: From the 132 patients in our cohort, we obtained 200 contemporary imaging examination pairs. MS-CT was
used as the preferred examination in determining the presence of an endoleak. The true-positive rate for the detection of
endoleaks with CEUS imaging was 42% (84 of 200), the false-positive rate was 4% (8 of 200), the true-negative rate was
52% (105 of 200), and the false-negative rate was 2% (3 of 200). The sensitivity of CEUS imaging was therefore 97%, and
the speciﬁcity was 93%. The McNemar test value was 0.227, and the k coefﬁcient was 0.889.
Conclusions: CEUS imaging appears to be as good as MS-CT angiography in the detection of endoleaks in the follow-up
after EVAR, with the added advantages of no radiation dose and no nephrotoxicity of the contrast agents. A switch of the
preferred examination from MS-CT to CEUS imaging should be considered. (J Vasc Surg 2013;58:340-5.)There are two options in treating an abdominal aneu-
rysm: on one hand, the open surgical repair, which was ﬁrst
described in 1951, and on the other, the endovascular
aneurysm repair (EVAR), which has been in practice since
1991.1 Over the years, EVAR has gained more and more
acceptance.2 EVAR is less invasive than open repair but
needs lifelong surveillance because complications may
occur after the procedure, including stent graft migration,
kinking, or endoleak.3,4
Endoleaks are the most common complication after
EVAR and are deﬁned as the persistence of blood ﬂow
outside the lumen of the endoluminal graft but within
the aneurysm sac.1,5 White et al6 categorized endoleaks
into ﬁve groups. In type I endoleaks, the blood ﬂow comes
from a stent graft attachment site, type II originates over
collateral vessels, type III results from stent graft failure,the Department for Clinical Radiologya and Department of Surgery,b
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Different imaging modalities are used for the follow-up
after EVAR. Surveillance with computed tomography (CT)
is currently seen as the preferred examination, but duplex
ultrasound (DUS) and contrast-enhanced US (CEUS)
imaging are used as well and are gaining ground.8
In the follow-up after EVAR, multislice CT (MS-CT)
is a good tool to detect stent migration and kinking as
well as endoleaks, but with its radiation dose, nephrotoxic
contrast agents, and high costs, it also has several draw-
backs.3,8,9 CEUS imaging, however, may not be able to
detect stent migration or kinking but is excellent in detect-
ing endoleaks because of its ability to locate velocity and
blood ﬂow direction.1,10 Furthermore, it is noninvasive,
has no radiation exposure, and is widely available with rela-
tively low costs.11
Other studies have already shown a good correlation
between CEUS imaging and MS-CT in the detection of
endoleaks.8,12 The aim of this study was to show in a rela-
tively large group of patients that CEUS imaging is as good
as MS-CT in detecting endoleaks and even better than
MS-CT in classifying the different endoleak types.
METHODS
This study was approved by the University Hospitals-
Grosshadern, Ludwig-Maximilians-University Ethics Com-
mittee (Munich, Germany). The study data were collected
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compliance with the principles of the Helsinki/Edinburgh
Declaration of 2002 and performed in accordance with the
guidelines of Clinical Haemorheology and Microcircula-
tion.13 The consent of all patients was obtained before the
study.
Study design and patient population. This was
a retrospective study from February 2006 until February
2011 of 171 patients who received 489 CEUS and 421
MS-CT examinations after EVAR. Owing to the inclu-
sion and exclusion criteria, 200 contemporary examination
pairs from 132 patients of this cohort were included,
assuming independence between multiple examinations per
patient. MS-CT was used as the gold standard in deter-
mining the presence of an endoleak.
Inclusion criteria. Only patients undergoing follow-
up after EVAR who had received at least one CEUS
examination after the stent implantation (bi-iliac or mon-
oiliac stent graft) were included. Because this is a retro-
spective study, MS-CT and CEUS imaging were not always
done on the same day; therefore, we compared examina-
tions that were performed on the same day or #30 days.
Exclusion criteria. Patients with an abdominal tube
stent were excluded. Additional exclusion criteria were
patients with acute heart failure, acute myocardial infarc-
tion, known allergy to SonoVue (Bracco, Milan, Italy),
and patient noncompliance.
MS-CT protocol. The patients were examined using
a standard protocol for an arterial and a venous phase
examination with a Somaton Sensation 16-, 64-, or 128-
slice detector MS-CT scanner (Siemens Medical Systems,
Forchheim, Germany). For the Sensation 16, collimation
and table feed were 16  0.75 mm; rotation time,
0.5 seconds; pitch, 1; slice thickness, 0.75 mm; and
reconstruction interval, 0.6 mm. Tube voltage was set to
100 kV, and the exposure time  tube current product was
220 mA using Care Dose 4D (Siemens Medical Systems).
For the Sensation 64, collimation and table feed were 64 
0.6 mm; rotation time, 0.33 seconds; pitch, 0.9; slice
thickness, 0.75 mm; and reconstruction interval, 0.5 mm.
Tube voltage was set to 120 kV, and the exposure time 
tube current product was 200 mA using Care Dose 4D.
For the Sensation 128, collimation and table feed was 64 
0.6 mm; rotation time, 0.3 seconds; pitch, 1.2; slice
thickness, 1.0 mm; and reconstruction interval, 0.8 mm.
Tube voltage was set to 80 kV, and the exposure time 
tube current product was 120 mA using Care Dose 4D.
Because this is a retrospective study, the image resolution
was performed with the latest state-of-the-art equipment
available at that time.
Before each contrast agent injection, patients were
informed in detail about possible risks such as allergic reac-
tions. The contrast agent was injected into an antecubital
vein as a bolus, using a dual-head power injector with
a ﬂow rate of 5 mL/s. A total of 100 to 120 mL Imeron
(Bracco) with an iodine concentration of 350 mg/mL
was administered, followed by 50 mL saline (0.9% NaCl).
The appropriate scan delay for the arterial and venousphase after contrast agent administration was determined
by semiautomatic bolus tracking on the thoracic aorta.
A threshold of 100 HU was selected for the tracking re-
gion of interest. The imaged volume included the entire
abdominal aorta from its lower thoracic portion and the
common and external iliac arteries to the upper femoral
arteries. The acquisition direction was craniocaudal. Im-
ages were reconstructed as thin-slice maximum-intensity
projections with increments of 0.6 mm and slice of 0.75
mm in coronal planes. All images were stored in the picture
archiving and communication system and were examined
by two experienced radiologists in a consensus reading.
CEUS protocol. An experienced sonographer per-
formed the US examinations in the follow-up after
EVAR of abdominal aortic aneurysms on a Siemens
ACUSON Sequoia 512 and a Siemens ACUSON S2000
(Siemens Healthcare, Erlangen, Germany) using a curved-
array 4-MHz multifrequency transducer. An internally
standardized scanning protocol was used for assessing the
abdominal aneurysm. The protocol included transverse and
sagittal imaging. A maximum of two focus zones were
adapted to the area of interest. The ﬁeld of view was
minimized to the target area and automatic grayscale
optimization was used.
The color gain in color-coded DUS (CDUS) imaging
was selected to be just sufﬁcient to avoid overwriting arte-
facts. A conventional grayscale was initially performed, fol-
lowed by CDUS imaging. Detected signals via CDUS were
recorded, but no systematic search of an endoleak was per-
formed. During the CDUS, cine loops were acquired and
stored in the picture archiving and communication system.
Mean examination time was 5 to 10 minutes.
For the CEUS examination, an intravenous bolus injec-
tion of 1.0 mL SonoVue, a second-generation blood pool
contrast agent, consisting of stabilized microbubbles of
sulfur hexaﬂuoride, was administered into an antecubital
vein through an 18-gauge needle and was followed by
a ﬂush of 10 mL saline solution (0.9% NaCl). Other studies
used 2.4 mL contrast agent, but we gained very good visual
results with less contrast agent.12,14 CEUS used continuous
low mechanical index (0.15-0.19) real-time tissue harmonic
imaging contrast pulse sequencing imaging. The US device
features a high-performance processor and allows the docu-
mentation of dynamic image sequences in cine mode by
digital frame buffer. Administration of 1.0-mL contrast
agent allows diagnostic views for about 3 minutes. After
5 minutes, almost all of the contrast has vanished.
Data and statistical analysis. Data evaluation was per-
formed using the digitally stored video sequence and image
data sets of CEUS imaging and MS-CT. An endoleak was
deﬁned as an extravasation of contrast between the aneu-
rysm wall and the prosthesis.1 CEUS cineloops and MS-CT
images were assessed by consensus reading by two experi-
enced radiologists. Radiologists reading one test did not
have access to the results of the other test. MS-CT was
used as the reference standard in determining the presence
of an endoleak. CEUS ﬁndings were considered true
positive if the MS-CT revealed evidence of an endoleak; if









Mean 6 SD 70.40 6 8.6 70.37 6 8.1 70.60 6 12.3
Median (range) 71.0 (34-91) 71.0 (50-91) 73.5 (34-85)
SD, Standard deviation.
Fig 1. Ultrasound B-scan imaging in the axial plane shows an
abdominal aneurysm (yellow arrow) with iliac segments of the stent
graft (green arrows).
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considered false positive. Conventional measures of diag-
nostic performance, such as sensitivity and speciﬁcity for
the detection of an endoleak, were calculated.
The McNemar test and k coefﬁcient were used to
assess agreement between MS-CT and CEUS imaging in
detecting endoleaks without considering MS-CT to be
the reference examination. For all tests, values of P # .05
were considered to indicate a signiﬁcant difference. Statis-
tical analysis was performed with PASW/SPSS 18 software
(IBM Corp, Armonk, NY).Fig 2. A contrast-enhanced ultrasound (CEUS) image in the axial
plane of the same patient in Fig 1 shows the abdominal aneurysm
(yellow arrow), the iliac segments of the stent graft (green arrow),
and a type II A endoleak (red arrow).RESULTS
Between February 2006 and February 2011, we ob-
tained a cohort of 171 patients after EVAR who received
489 CEUS and 421 MS-CT examinations during the
follow-up. No patient was excluded because of medical
conditions such as allergies or major pulmonary or heart
diseases. No patient withdrew permission for the examina-
tion. Owing to our study design exclusion criteria, 39
patients were withdrawn because of time mismatch
between imaging studies.
The cohort was an average age of 70.4 6 8.6 years
(range, 34-91 years) and consisted of 151 men (84.4%)
and 20 women (11.7%). Two study patients received new
stent grafts during the follow-up, so a total of 173 stents
were examined. Patient characteristics are detailed in
Table I.
All examinations were performed successfully and
without complication or adverse effects. There was no
mismatch outside the 30-day window between tests.
Owing to the inclusion and exclusion criteria, 200 contem-
porary examination pairs 630 days from 132 patients of
the 489 CEUS and 421 MS-CT examinations could be
matched. We excluded 39 patients from the study popula-
tion due to a mismatch according our MS-CT and CEUS
examination time (630 days).
CEUS examination before MS-CT. Owing to our
inclusion and exclusion criteria, 77 of 200 patients had
the CEUS examination up to 30 days before MS-CT
examination.
CEUS and MS-CT examinations performed the
same day. Of our study population of 200 patients, 73
were included and underwent MS-CT and CEUS
imaging the same day.
CEUS examinations after MS-CT. Owing to our
inclusion and exclusion criteria, 50 of 200 patients hadthe CEUS examination up to 30 days before the MS-CT
examination.
Total endoleaks. During the follow-up of the 173
stent grafts, we detected 79 primary endoleaks that devel-
oped within the ﬁrst 30 days after stent graft placement, 16
secondary endoleaks that developed after the ﬁrst 30 days
after stent graft placement (Figs 1-3), and no endoleak was
found in 76 (Figs 4-6). In two patients, it was not possible
to tell if the endoleak was primary or secondary. During the
follow-up interval, 97 of 173 patients (56.1%) showed an
endoleak, but 19 of the primary endoleaks sealed
spontaneously.
CEUS imaging. Of the 200 image pairs evaluated, the
CEUS examination showed a true-positive result for the
detection of endoleaks in 84 (42%), false-positive in eight
(4%), true-negative in 105 (52.5%), and false-negative in
three (1.5%). Owing to the limited number of false-negative
Fig 3. Computed tomography (CT) angiography in the axial
plane in the same patient in Figs 1 and 2 shows the abdominal
aneurysm (yellow arrow), the iliac segments of the stent graft (green
arrow), and the type II A endoleak (red arrow).
Fig 4. Ultrasound B-scan imaging in the axial plane shows an
abdominal aneurysm (yellow arrow) with the stent graft (green
arrow).
Fig 5. Contrast-enhanced ultrasound (CEUS) image in the axial
plane in the same patient as in Fig 4 shows the abdominal aneu-
rysm (yellow arrow), the stent graft (green arrow), and a type II A
endoleak (red arrow).
Fig 6. No endoleak is detected on computed tomography angi-
ography in the axial plane in the same patient as in Figs 4 and 5.
The yellow arrow designates the aneurysm sac, and the green arrow
shows the stent graft.
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study. With these results, we achieved a sensitivity of 96.6%
and a speciﬁcity of 92.9%. The McNemar test P value was
.227 and k was 0.889 (Table II).
MS-CT assessment. Within the 200 imaging pairs,
the MS-CT was positive for endoleaks in 87 (43.5%), and
detected no endoleak in 113 (56.5%). Table III reports the
differences of endoleaks detected by MS-CT and CEUS
imaging. In ﬁve images, CEUS detected an endoleak where
none was seen in MS-CT, and in four images, MS-CT
detected an endoleak but was not able to identify where
the contrast agent came from.
DISCUSSION
Patients need lifelong surveillance after EVAR because
complications, especially endoleaks, can occur at any timeafter stent graft placement and could end in rupture of
the aneurysmal sac.15 Because of the radiation dose, the
use of nephrotoxic contrast agent, and the relatively high
costs induced by MS-CT, there are debates about a reliable
alternative to MS-CT for the surveillance after EVAR.3,12
US imaging was often criticized in the past, but in recent
years, CDUS imaging has been seen as a safe and effective
modality for the observation after EVAR.16 US imaging
is far less invasive and less expensive, involves no radiation,
and is therefore suitable for long-term follow-up. The sensi-
tivity and speciﬁcity for detecting endoleaks after EVAR,
however, is signiﬁcantly lower for standard US imaging
compared with contrast-enhanced MS-CT (CDUS only
had a sensitivity of 33% and a speciﬁcity of 92.8%).1 But the
sensitivity of US examinations can be extended by using
contrast agents because detection of high and slow velocities
for assessment of blood ﬂow is possible.17 Cantisani et al4
Table III. Classiﬁcation of endoleaks detected with
multislice computed tomography (MS-CT) and contrast-
enhanced ultrasound (CEUS) imaging in 200
examination pairs
Variable MS-CT, No. CEUS, No.
No endoleak detected 113 108
Endoleak detected
Type Ia 12 12
Type Ib 7 8
Type Ic 1 1
Type Ia þ Ib 2 3
Type IIa (inferior mesenteric artery) 23 24
Type IIa (arteria lumbalis) 25 27
Type IIb 7 9
Type III 3 3
Type IV 1 1
Type Ia þ IIa 1 2
Type Ib þ IIa 0 1
Type Ic þ IIa 1 1
Leak of unknown origin 4 0
Table II. Endoleaks detected with multislice computed
tomography (MS-CT) and contrast-enhanced ultrasound
(CEUS) imaging in 200 examination pairs
Variable CEUSþ, No. CEUS, No. Total, No.
MS-CTþ 84 3 87
MS-CT 8 105 113
Total 92 108 200
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better than CDUS and similar to MS-CT.
The main aim of our study was to evaluate the perfor-
mance of CEUS examinations compared with MS-CT.
Owing to the previously published report that shows the
advantage of CEUS compared with CDUS, we did not
include CDUS in our results.1
In 2006, Carraﬁello et al18 concluded that CEUS
imaging is better in detecting the origin of an endoleak
and is therefore better than MS-CT in classifying it.
Many studies in the last few years showed encouraging
results for CEUS imaging to be a good tool in the
follow-up surveillance after EVAR. In their study from
2009, Iezzi et al12 compared CEUS imaging with
MS-CT and obtained a sensitivity of 97.5% and speciﬁcity
of 81.8%. The k test analysis showed a value >0.89. Perini
et al2 achieved an observed agreement of 90.9%, conﬁrmed
by a McNemar test of 0.25.
Sensitivity between CEUS and MS-CT in other studies
ranged between 50% and 100%, and speciﬁcity was be-
tween 65% and 100%.3 But one has to admit that in the
studies that calculated a sensitivity of 100%, the data set
was very small, with only 20 to 30 patients.3,19
In 2010, Mirza et al20 performed a systematic review
and meta-analysis of seven studies that compared CEUS
imaging with MS-CT and calculated a pooled sensitivity
of 98% and a speciﬁcity of 88%. Ten Bosch et al21
concluded that CEUS imaging was even better than
MS-CT in detecting endoleaks, especially type II (53% vs
22%). With the results of our study, we support the state-
ments of the other studies. We were able to show, with
a sensitivity of 96.6% and a speciﬁcity of 92.9%, that
CEUS is indeed appropriate as an accurate follow-up
method after EVAR. In our study, CEUS even detected
ﬁve endoleaks more than MS-CT (especially type II endo-
leaks), and in four patients, MS-CT detected an endoleak
but was not able to identify where the contrast agent
came from. This is mainly because of the real-time dynamic
nature of CEUS imaging as well as the relative persistence
of the contrast agent in the circulation, which enables
vessels to be assessed in several contrast phases18,22 and
allows CEUS to provide a better classiﬁcation of
endoleaks.4
The existence of an endoleak is a cause for concern
because it perfuses and pressurizes the aneurysmal sac,
which can lead to its enlargement and the associated risk
of rupture.7 Because of the anterograde blood ﬂow, typeI and III endoleaks need an earlier intervention than type
II endoleaks.7
One limitation of our study is the problem of being
a retrospective study. To acquire MS-CT and CEUS exam-
ination pairs, we matched examinations that were per-
formed #30 days. Thus, a disagreement between the
MS-CT and CEUS examination in the detection or classi-
ﬁcation of an endoleak could be caused by the interval
between both, because an endoleak is not static and can
change over time.
Another limitation is caused by including more exami-
nation pairs of one patient, assuming they are independent.
We believe this to be acceptable given that an endoleak can
seal spontaneously. However, one can argue that if an
examination method is not able to detect or classify an
endoleak for morphologic or other reasons in one examina-
tion, it is probably not able to detect it the next time.
Acknowledged limitations of all US methods include
operator-dependence and the two-dimensional view, which
sometimes makes fast orientation difﬁcult.11 Additional
factors complicating US imaging include obesity, ascites,
or intervening bowel gas.2
The 56% rate of endoleaks after EVAR in our study is
quite high. In other literature, the frequency ranges
between 15% and 52%.23 However, 19 of these endoleaks
sealed spontaneously, so the frequency is not signiﬁcantly
higher than in other studies. Because we did not look at
the different stent grafts, we cannot say if there was
a correlation between the existence of an endoleak and
a particular stent graft, as was suggested by Hiatt and
Rubin.7
Perhaps in unclear cases, image fusion in which regis-
tered MS-CT images are simultaneously shown with the
respective US sectional plane is the link between both
imaging modalities and could combine the advantage of
both techniques.11
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In our study, we were able to show that CEUS imaging
is an appropriate examination method for the follow-up of
patients who undergo EVAR and is at least equivalent to
MS-CT in detecting endoleaks. MS-CT is seen as the
preferred examination for the follow-up after EVAR at
the moment, but it has some disadvantages, including its
nephrotoxicity and radiation exposure.3 Since 2011,
CEUS imaging is ﬁrst recommended for the detection,
classiﬁcation, and follow-up of abdominal aortic aneurysm
endoleaks in the European Federation of Societies for
Ultrasound in Medicine and Biology guidelines.10
Lawrence-Brown et al23 and Verhoeven et al24 suggest
switching from MS-CT to US imaging when the aneurysm
sac starts to shrink and no problems occur. MS-CT should
be used for patients with an enlarging aneurysm diameter
or a suspected endoleak. MS-CT should not be replaced
totally by CEUS imaging. Both methods should be used
in an individual way according to each patient’s needs.
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